Search Browse Earnings

Sana Biotechnology, Inc. — SlamSEC

Sana Biotechnology, Inc.

Nasdaq:SANA

Biological Products, (No Diagnostic Substances)·SEATTLE, WA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$275.6M

FY 2025

Net Income

-$283.3M

FY 2025

EPS (Diluted)

-$1.46

FY 2025

Stock Price

$3.33

+5.9%

2026-03-10

52W Range

$1.26 – $6.55

P/E Ratio

-2.3x

Market Cap

$888.7M

Cash

$133.5M

FY 2025

Total Debt

—

Net Cash

$133.5M

Enterprise Value

$755.1M

Debt / EBITDA

0.5x

FY 2025

EV / EBITDA

-2.7x

Employees

—